MahaRedaFarhatMD
Pulmonology • Boston, MACritical Care Medicine, Pleural Disease
Assistant Professor of Medicine, Harvard Massachusetts General Hospital
Dr. Farhat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Massachusetts General Hospital Bulfinch 148
Boston, MA 02114Phone+1 617-726-1721
Education & Training
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2012- Massachusetts General HospitalResidency, Internal Medicine, 2005 - 2008
McGill University Faculty of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2007 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 11 citationsPhase variation as a major mechanism of adaptation incomplex.Roger Vargas Jr, Michael J Luna, Luca Freschi, Maximillian Marin, Ruby Froom
Proceedings of the National Academy of Sciences of the United States of America. 2023-07-11 - 5 citationsOptimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications.Tara E Ness, Lennard Meiwes, Alexander Kay, Rojelio Mejia, Christoph Lange
Microbiology Spectrum. 2023-02-14 - 52 citationsPopulation structure, biogeography and transmissibility of Mycobacterium tuberculosisLuca Freschi, Roger Vargas, Ashaque Husain, S.M. Mostofa Kamal, Alena Skrahina
Nature Communications. 2021-10-20
Journal Articles
- Gastrointestinal Complications in Critically Ill Patients with and Without COVID-19Maha Farhat, MD, JAMA
Press Mentions
Study Identifies Need to Improve Patient Retention in the National TB Elimination Programme, Highlights Patients’ Trust Relationship with Private ProvidersOctober 31st, 2021- Strain-Specific Behavior of Mycobacterium Tuberculosis in A549 Lung Cancer Cell LineMarch 25th, 2021
- Late DetectionMarch 22nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
